Cargando…
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells
Breast cancer is one of the leading causes of cancer death among women in the United States. Patients expressing the estrogen and progesterone receptor (ER and PR) and human epidermal growth factor 2 (HER-2) tumor markers have favorable prognosis and efficacious therapeutic options. In contrast, tum...
Autores principales: | Vogel, Rachel Isaksson, Coughlin, Kathleen, Scotti, Alessandra, Iizuka, Yoshie, Anchoori, Ravi, Roden, Richard B. S., Marastoni, Mauro, Bazzaro, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414179/ https://www.ncbi.nlm.nih.gov/pubmed/25784654 |
Ejemplares similares
-
Stressing the Ubiquitin-Proteasome System without 20S Proteolytic Inhibition Selectively Kills Cervical Cancer Cells
por: Anchoori, Ravi K., et al.
Publicado: (2011) -
Survey of the Phosphorylation Status of the Schizosaccharomyces pombe Deubiquitinating Enzyme (DUB) Family
por: McLean, Janel R., et al.
Publicado: (2010) -
Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis
por: Ohanna, Mickael, et al.
Publicado: (2022) -
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response
por: Snyder, Nathan A., et al.
Publicado: (2021) -
Deubiquitinating enzymes (DUBs): DoUBle-edged swords in CNS autoimmunity
por: Ruan, Jing, et al.
Publicado: (2020)